
News|Podcasts|July 30, 2025
Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Kevin Chen, PharmD, MS, BCOP, CPP; and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the newly approved drug taletrectinib.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Understanding RSV in Older Adults: Risks, Symptoms, and Barriers to Vaccination
2
Patients Critically Ill With COVID-19 Have Heightened Risk of Pulmonary Fibrosis
3
Study Finds CGMs Could Overestimate Food’s Impact on Blood Sugar Among Nondiabetic Individuals
4
Pharmacists Can Provide Trusted Medical Advice in an Era of Fractured Health Care
5